Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-10-17 9:05 pm Unchanged | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,211,262 0.5% | 0 (Unchanged) | View |
| 2023-10-16 8:56 pm Unchanged | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,211,262 0.5% | 0 (Unchanged) | View |
| 2023-06-07 9:44 pm Sale | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,211,262 10.9% | -60,913 (-4.79%) | View |
| 2023-05-22 07:04 am Sale | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,272,175 12.2% | -551,815 (-30.25%) | View |
| 2021-04-27 9:45 pm Purchase | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,823,990 19.2% | 616,817 (+51.10%) | View |
| 2021-02-11 10:59 am Purchase | 13G | SCYNEXIS INC SCYX | Puissance Life Science Opportunities Fund VI | 255,718 2.34% | 255,718 (New Position) | View |
| 2020-05-22 07:38 am Purchase | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,207,173 13.1% | 1,207,173 (New Position) | View |
| 2020-02-13 8:40 pm Sale | 13G | SCYNEXIS INC SCYX | Puissance Life Science Opportunities Fund VI | 126,865 0.002% | -4,882,965 (-97.47%) | View |